Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.7K citations

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Takashi Tsuruo, Harumi Iida, Shigeru Tsukagoshi et al. · PubMed · 1981 · 1.5K citations

Chemoprevention Strategy, Vincristine Resistance, Medicine +11

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

Prakash Mistry, Alistair Stewart, Wendy Dangerfield et al. · PubMed · 2001 · 350 citations

Pharmacotherapy, Tumor Biology, P-glycoprotein-mediated Multidrug Resistance +17

Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma

Lajos Pusztai, Peter J. Wagner, Nuhad K. Ibrahim et al. · Cancer · 2005 · 298 citations · Full text

The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein

Catherine Martin, G. Berridge, Prakash Mistry et al. · British Journal of Pharmacology · 1999 · 259 citations · Full text